SEATTLE, June 12, 2024--Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, and Boehringer Ingelheim, one of the largest innovators in animal disease prevention and treatment globally, today announced a strategic collaboration to provide pets and their families increased access to high-quality healthcare and enhanced disease treatment and protection.
Focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position continue to drive Trupanion (TRUP).
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders should be happy to see the share price up 26% in the last month. But that...